CBS 2019
CBSMD教育中心
中 文

Scientific Library

Abstract

Recommended Article

Effects of Icosapent Ethyl on Total Ischemic Events: From REDUCE-IT A Genotype-Guided Strategy for Oral P2Y12 Inhibitors in Primary PCI Clinical Phenogroups in Heart Failure With Preserved Ejection Fraction: Detailed Phenotypes, Prognosis, and Response to Spironolactone Impact of chronic obstructive pulmonary disease on prognosis after percutaneous coronary intervention and bypass surgery for left main coronary artery disease: an analysis from the EXCEL trial When, where, and how to target vascular inflammation in the post-CANTOS era? 2-Year Outcomes After Stenting of Lipid-Rich and Nonrich Coronary Plaques The spectrum of chronic coronary syndromes: genetics, imaging, and management after PCI and CABG Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes

Original ResearchVolume 73, Issue 22, June 2019

JOURNAL:J Am Coll Cardiol. Article Link

Effects of Icosapent Ethyl on Total Ischemic Events: From REDUCE-IT

DL Bhatt, G Steg, and on behalf of the REDUCE-IT Investigators. Keywords: eicosapentaenoic acid; icosapent ethyl; statin; time-to-first-event;

FULL TEXT PDF